Table of Contents

company-logo

Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. Janux Therapeutics, Inc. is also developing a Tumor Activated Immunomodulator (TRACIr) costimulatory bispecific product candidate against programmed death-ligand 1 and CD28 designed to improve the anti-tumor activity of T cells. In addition, its EGFR-TRACTr is designed to target EGFR in many cancer types with multiple approved monoclonal antibodies. The company was incorporated in 2017 and is headquartered in La Jolla, California.

Janux Therapeutics Dividend Announcement

• Janux Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Janux Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Janux Therapeutics Dividend History

Janux Therapeutics Dividend Yield

Janux Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Janux Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Janux Therapeutics Financial Ratios

P/E ratio-48.44
PEG ratio0.57
P/B ratio4.47
ROE-10.46%
Payout ratio0.00%
Current ratio38.80
Quick ratio38.80
Cash Ratio1.56

Janux Therapeutics Dividend FAQ

Does Janux Therapeutics stock pay dividends?
Janux Therapeutics does not currently pay dividends to its shareholders.
Has Janux Therapeutics ever paid a dividend?
No, Janux Therapeutics has no a history of paying dividends to its shareholders. Janux Therapeutics is not known for its dividend payments.
Why doesn't Janux Therapeutics pay dividends?
There are several potential reasons why Janux Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Janux Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Janux Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Janux Therapeutics a dividend aristocrat?
Janux Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Janux Therapeutics a dividend king?
Janux Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Janux Therapeutics a dividend stock?
No, Janux Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Janux Therapeutics stocks?
To buy Janux Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Janux Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.